Galectin Therapeutics GALT Q2 2025 earnings
Reported August 14, 2025 · Before market open
EPS estimate-$0.16
Next report
Aug 13, 2026 (In 4 weeks)EPS estimate-$0.09
Versus estimates
Revenue
Diluted EPS
Ask the moment Galectin Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Galectin Therapeutics report Q2 2025 earnings?
- Galectin Therapeutics (GALT) reported Q2 2025 earnings on August 14, 2025 before market open.
- What were Galectin Therapeutics's Q2 2025 revenue and EPS?
- Galectin Therapeutics reported diluted EPS of $-0.12 for Q2 2025.
- Did Galectin Therapeutics beat estimates in Q2 2025?
- EPS beat the consensus estimate of $-0.16 by $0.04.
- How did Galectin Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS grew 40.0% from $-0.20.
- Where can I find Galectin Therapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001140361-25-031039) directly on SEC EDGAR. The filing index links above go to sec.gov.